BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee S, Kim YY, Shin J, Hwang SH, Roh YH, Chung YE, Choi JY. CT and MRI Liver Imaging Reporting and Data System Version 2018 for Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis. J Am Coll Radiol 2020;17:1199-206. [PMID: 32640250 DOI: 10.1016/j.jacr.2020.06.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Marks RM, Masch WR, Chernyak V. LI-RADS: Past, Present, and Future, From the AJR Special Series on Radiology Reporting and Data Systems. American Journal of Roentgenology 2021;216:295-304. [DOI: 10.2214/ajr.20.24272] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bae JS, Lee DH, Lee SM, Suh KS, Lee KW, Yi NJ, Lee KB, Kim H, Han JK. Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplantation According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma. AJR Am J Roentgenol 2022. [PMID: 35138137 DOI: 10.2214/AJR.21.27186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cannella R, Cammà C, Matteini F, Celsa C, Giuffrida P, Enea M, Comelli A, Stefano A, Cammà C, Midiri M, Lagalla R, Brancatelli G, Vernuccio F. Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC. Diagnostics 2022;12:1308. [DOI: 10.3390/diagnostics12061308] [Reference Citation Analysis]
4 Cannella R. Editorial Comment: LI-RADS Provides High Accuracy for Liver Transplant Eligibility in High-Risk Patients. AJR Am J Roentgenol 2022;:11. [PMID: 35195437 DOI: 10.2214/AJR.22.27553] [Reference Citation Analysis]
5 Shin J, Lee S, Kim SS, Chung YE, Choi JY, Park MS, Kim MJ. Characteristics and Early Recurrence of Hepatocellular Carcinomas Categorized as LR-M: Comparison with Those Categorized as LR-4 or 5. J Magn Reson Imaging 2021. [PMID: 33891790 DOI: 10.1002/jmri.27650] [Reference Citation Analysis]
6 Zhao C, Dai H, Shao J, He Q, Su W, Wang P, Tang Q, Zeng J, Xu S, Zhao J, Xiang S. Accuracy of Various Forms of Contrast-Enhanced MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:680691. [PMID: 34950573 DOI: 10.3389/fonc.2021.680691] [Reference Citation Analysis]
7 Noda Y, Kawai N, Ishihara T, Tsuboi Y, Kaga T, Miyoshi T, Hyodo F, Matsuo M. Optimized scan delay for late hepatic arterial or pancreatic parenchymal phase in dynamic contrast-enhanced computed tomography with bolus-tracking method. Br J Radiol 2021;94:20210315. [PMID: 33956484 DOI: 10.1259/bjr.20210315] [Reference Citation Analysis]
8 Mettikanont P, Kalluri A, Bittermann T, Phillips N, Loza B, Rosen M, Siegelman E, Furth E, Abt P, Olthoff K, Shaked A, Hoteit M, Reddy KR. The Course of LIRADS 3 and 4 Hepatic Abnormalities as Correlated with Explant Pathology: A Single Center Experience. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.02.005] [Reference Citation Analysis]
9 Ghadimi M, Birnbaum J, Kamel IR, Sirlin CB, Chernyak V. What proportion of LI-RADS 5 observations reported in clinical practice do not meet LI-RADS 5 criteria? Eur Radiol 2021. [PMID: 34807269 DOI: 10.1007/s00330-021-08389-5] [Reference Citation Analysis]
10 Kwan SW, Lee CI. Data, Distilled. J Am Coll Radiol 2020;17:1197-8. [PMID: 33012374 DOI: 10.1016/j.jacr.2020.08.009] [Reference Citation Analysis]
11 Shin J, Lee S, Yoon JK, Chung YE, Choi J, Park M. LI‐RADS Major Features on MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis. J Magn Reson Imaging 2021;54:518-25. [DOI: 10.1002/jmri.27570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chernyak V, Sirlin CB. Editorial for "A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features". J Magn Reson Imaging 2021. [PMID: 34669224 DOI: 10.1002/jmri.27963] [Reference Citation Analysis]
13 Kim TH, Woo S, Joo I, Bashir MR, Park MS, Burke LMB, Mendiratta-Lala M, Do RKG. LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data. Abdom Radiol (NY) 2021;46:3717-28. [PMID: 34027566 DOI: 10.1007/s00261-021-03122-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Tsukahara Y, Okajima Y, Yamada A, Momose M, Uehara T, Shimizu A, Soejima Y, Fujinaga Y. The peritumoral hypointense rim around hepatocellular carcinoma on T2*-weighted magnetic resonance imaging: radiologic-pathologic correlation. World J Surg Oncol 2021;19:41. [PMID: 33549104 DOI: 10.1186/s12957-021-02152-2] [Reference Citation Analysis]
15 Kim YY, Lee S, Shin J, Son WJ, Shin H, Lee JE, Hwang JA, Chung YE, Choi JY, Park MS. Diagnostic Performance of Liver Imaging Reporting and Data System Version 2017 Versus Version 2018 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Comparative Studies. J Magn Reson Imaging 2021. [PMID: 33929784 DOI: 10.1002/jmri.27664] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Elena Laino M, Viganò L, Ammirabile A, Lofino L, Generali E, Francone M, Lleo A, Saba L, Savevski V. The added value of Artificial Intelligence to LI-RADS categorization: a systematic review. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chernyak V. Editorial for "Diagnostic Performance of Liver Imaging Reporting and Data System Version 2017 Versus Version 2018 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Comparative Studies". J Magn Reson Imaging 2021;54:1920-1. [PMID: 34155706 DOI: 10.1002/jmri.27797] [Reference Citation Analysis]